Moderna, Inc.: Working Hard But Competition Is Working Harder
MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...
Why Moderna, Inc. (MRNA) Is Among the Best Healthcare Stocks To Buy According to Analysts
We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to ...
Nasdaq7d
Moderna (MRNA) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
Moderna (MRNA) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook gives ...
Moderna, Inc. (NASDAQ:MRNA) Stake Lessened by Janney Montgomery Scott LLC
Janney Montgomery Scott LLC lowered its holdings in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 21.0% in the fourth quarter, ...
Moderna swings to Q4 loss after nearly 66% drop in revenue
Moderna (NASDAQ:MRNA) shares fell ~5% in the premarket on Friday after the COVID-19 vaccine maker, with its Q4 2024 results, topped the consensus for revenue but missed Street forecasts for earnings ...
Why Moderna Inc. (MRNA) Crashed on Monday
We recently compiled a list of the The 10 Worst-Performing Stocks on Monday. In this article, we are going to take a look at ...
Nasdaq11d
MRNA May 16th Options Begin Trading
Investors in Moderna Inc (Symbol: MRNA) saw new options become available today, for the May 16th expiration. One of the key data points that goes into the price an option buyer is willing to pay ...